CTCX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 29.00%

Insider Buying (Last 12 Months): $66,606.67

Insider Selling (Last 12 Months): $0.00

Carmell Insider Trading History Chart

Carmell Share Price & Price History

^$0.26

▼ -0.0052 (-1.98%)

As of 03/12/2025 01:00 AM ET

Days: 30 | 90 | 365

Carmell Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/10/2024	Bryan J Cassaday	CFO	Buy	475	$0.46	$218.50	4,250
9/6/2024	Kathryn Gregory	Director	Buy	1,260	$0.51	$642.60	22,500
8/30/2024	Scott M Frisch	Director	Buy	87	$0.57	$49.59	6,589
8/29/2024	Bryan J Cassaday	CFO	Buy	1,000	$0.57	$570.00	3,775
8/28/2024	Patrick A Sturgeon	Director	Buy	970	$0.56	$543.20	16,029
8/26/2024	Patrick A Sturgeon	Director	Buy	1,587	$0.72	$1,142.64	13,472
8/22/2024	Kathryn Gregory	Director	Buy	2,413	$0.72	$1,737.36	12,156
8/20/2024	Richard A Upton	Director	Buy	3,600	$0.89	$3,204.00	10,000
6/12/2024	Richard A Upton	Director	Buy	2,000	$2.20	$4,400.00	6,400
6/10/2024	Bryan J Cassaday	CFO	Buy	440	$2.50	$1,100.00	2,775
6/6/2024	Rajiv Shukla	CEO	Buy	2,100	$2.63	$5,523.00	72,103
5/30/2024	Rajiv Shukla	CEO	Buy	2,000	$2.50	$5,000.00	70,003
5/29/2024	Bryan J Cassaday	CFO	Buy	30	$2.60	$78.00	1,970
5/28/2024	Rajiv Shukla	CEO	Buy	20	$2.57	$51.40	68,003
5/24/2024	Rajiv Shukla	CEO	Buy	1,939	$2.57	$4,983.23	67,983
5/22/2024	Rajiv Shukla	CEO	Buy	4,051	$2.41	$9,762.91	63,944
5/20/2024	Rajiv Shukla	CEO	Buy	1,172	$2.22	$2,601.84	58,378
4/4/2024	Rajiv Shukla	CEO	Buy	8,680	$2.88	$24,998.40	57,206
12/14/2023	Gilles Spenlehauer	Director	Buy	313	$3.61	$1,129.93	4,790
12/12/2023	Richard A Upton	Director	Buy	2,000	$3.50	$7,000.00	2,000
12/7/2023	Scott M Frisch	Director	Buy	199	$3.07	$610.93	1,833
12/5/2023	Scott M Frisch	Director	Buy	277	$3.10	$858.70	1,147
11/30/2023	Rajiv Shukla	CEO	Buy	5,600	$2.66	$14,896.00	33,677
11/28/2023	Bryan J Cassaday	CFO	Buy	1,500	$2.85	$4,275.00	1,500
11/27/2023	Rajiv Shukla	CEO	Buy	2,100	$2.97	$6,237.00	20,562
11/24/2023	Rajiv Shukla	CEO	Buy	2,715	$2.95	$8,009.25	18,462
11/22/2023	Rajiv Shukla	CEO	Buy	1,185	$2.78	$3,294.30	15,747
11/20/2023	Rajiv Shukla	CEO	Buy	3,750	$2.62	$9,825.00	14,362
11/17/2023	Rajiv Shukla	CEO	Buy	2,000	$2.69	$5,380.00	10,612
8/28/2023	Rajiv Shukla	Chairman	Buy	2,100	$3.50	$7,350.00	8,612
8/28/2023	Randolph W Hubbell	CEO	Buy	100	$3.49	$349.00	2,750
8/25/2023	Randolph W Hubbell	CEO	Buy	200	$3.50	$700.00	2,650
8/24/2023	Rajiv Shukla	Chairman	Buy	500	$3.50	$1,750.00	5,912
8/23/2023	Randolph W Hubbell	CEO	Buy	200	$3.60	$720.00	2,250
8/21/2023	Rajiv Shukla	Chairman	Buy	100	$3.54	$354.00	5,412
8/21/2023	Randolph W Hubbell	CEO	Buy	300	$3.67	$1,101.00	1,950
8/18/2023	Rajiv Shukla	Chairman	Buy	4,100	$3.62	$14,842.00	5,312
8/17/2023	Randolph W Hubbell	CEO	Buy	450	$3.72	$1,674.00	450
8/16/2023	Rajiv Shukla	Chairman	Buy	1,112	$3.74	$4,158.88	1,112

See Full Table

SEC Filings (Institutional Ownership Changes) for Carmell (NASDAQ:CTCX)

24.22% of Carmell stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Carmell Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Citadel Advisors LLC	187,565	$54K	0.0%	N/A	0.897%
2/14/2025	Antara Capital LP	100,000	$28K	0.0%	N/A	0.478%
8/9/2024	Warberg Asset Management LLC	45,000	$60K	0.0%	N/A	0.216%
4/18/2024	Hubbell Strickland Wealth Management LLC	12,548	$32K	0.0%	N/A	0.065%
11/15/2023	Linden Advisors LP	75,000	$0.27M	0.0%	N/A	0.390%
11/14/2023	Meteora Capital LLC	1,780,919	$6.42M	1.1%	N/A	9.256%
11/7/2023	Cookson Peirce & Co. Inc.	15,000	$54K	0.0%	N/A	0.078%
11/1/2023	Carnegie Mellon University	103,061	$0.37M	0.5%	N/A	0.536%

Data available starting January 2016

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.

Today's Range

Now: $0.26

$0.24

$0.30

50 Day Range

MA: $0.36

$0.19

$0.69

52 Week Range

Now: $0.26

$0.17

$3.05

Volume

1,831,977 shs

Average Volume

7,786,396 shs

Market Capitalization

$5.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.51

Who are the company insiders with the largest holdings of Carmell?: Carmell's top insider shareholders include:
Rajiv Shukla (CEO)
Kathryn Gregory (Director)
Patrick A Sturgeon (Director)
Richard A Upton (Director)
Rajiv Shukla (Chairman)
Scott M Frisch (Director)
Gilles Spenlehauer (Director)
Bryan J Cassaday (CFO)
Randolph W Hubbell (CEO)
Learn More about top insider investors at Carmell.
Who are the major institutional investors of Carmell?: Carmell's top institutional investors include:
Citadel Advisors LLC — 0.90%
Antara Capital LP — 0.48%
Learn More about top institutional investors of Carmell stock.
Which major investors are buying Carmell stock?: During the previous quarter, CTCX stock was bought by institutional investors including:
Citadel Advisors LLC
Antara Capital LP
Within the last year, these company insiders have bought Carmell stock:
Rajiv Shukla (CEO)
Kathryn Gregory (Director)
Patrick A Sturgeon (Director)
Richard A Upton (Director)
Rajiv Shukla (Chairman)
Scott M Frisch (Director)
Gilles Spenlehauer (Director)
Bryan J Cassaday (CFO)
Randolph W Hubbell (CEO)
Learn More investors buying Carmell stock.